<DOC>
	<DOCNO>NCT00568204</DOCNO>
	<brief_summary>Atomised Methoxymethane-in-Aqua ( MEXYN-A ) new topical self-chilled , non-steroidal , non-flammable , pressurised spray embody one simultaneous application , currently recognise effective chemical , mechanical thermal anti-pruritic therapy hydrotherapy .</brief_summary>
	<brief_title>Study Effectiveness Mexyn-A</brief_title>
	<detailed_description>The primary clinical endpoint establish MEXYN-A efficacy safety abolish reduce pruritus relate cutaneous disease , insect bite poison ivy , within second application . The secondary endpoint measure itch free period result new intervention .</detailed_description>
	<mesh_term>Pruritus</mesh_term>
	<criteria>Patients suffer severe itch due : Atopic Dermatitis , contact dermatitis , psoriasis , urticaria , xerosis , prickly heat , genital pruritus , chicken pox , aquagenic pruritus , lichen planus , poison ivey , insect bite . Past experience use least one conventional medication pruritus conventional medication disorder patient suffer . Patients take antipruritic drug month prior participation . Patients take drug reason 2 day prior participate study .</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>pruritus , itch , mexyn-a , clearitch , magicool-plus</keyword>
</DOC>